Table 4 KEGG pathways in the top 50 over-expressed genes in bladder cancer vs. normal tissue
From: The targets of aspirin in bladder cancer: bioinformatics analysis
term description | count | false discovery rate | Gene ID |
|---|---|---|---|
Cell cycle | 12 | 1.76E-13 | CCNB1, ESPL1, MCM4, CCNE1, MCM2, BUB1B, CCNB2, CDC25A, GSK3B, CDC20, PTTG1, CDK1 |
Oocyte meiosis | 9 | 6.48E-09 | MAPK13, AURKA, CCNB1, ESPL1, CCNE1, CCNB2, CDC20, PTTG1, CDK1 |
Progesterone-mediated oocyte maturation | 6 | 2.67E-05 | MAPK13, AURKA, CCNB1, CCNB2, CDC25A, CDK1 |
p53 signaling pathway | 5 | 0.00015 | CCNB1, CCNE1, CCNB2, RRM2, CDK1 |
Cellular senescence | 6 | 0.00022 | MAPK13, CCNB1, CCNE1, CCNB2, CDC25A, CDK1 |
Human T-cell leukemia virus 1 infection | 6 | 0.0012 | ESPL1, CCNE1, BUB1B, CCNB2, CDC20, PTTG1 |